2877 — China Shineway Pharmaceutical Balance Sheet
0.000.00%
Last trade - 00:00- HK$7.82bn
- HK$1.75bn
- CNY4.52bn
- 95
- 86
- 99
- 100
Annual balance sheet for China Shineway Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,946 | 3,943 | 4,206 | 5,046 | 5,909 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 674 | 761 | 825 | 975 | 1,260 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,203 | 5,519 | 5,699 | 6,782 | 8,155 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,494 | 1,395 | 1,252 | 1,217 | 1,205 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 7,131 | 7,214 | 7,204 | 8,232 | 9,574 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,178 | 1,195 | 1,098 | 1,666 | 2,434 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,354 | 1,419 | 1,302 | 1,849 | 2,539 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Total Equity | 5,777 | 5,794 | 5,901 | 6,383 | 7,035 |
| Total Liabilities & Shareholders' Equity | 7,131 | 7,214 | 7,204 | 8,232 | 9,574 |
| Total Common Shares Outstanding |